作为血液静止材料的奇托桑最近的进展:血液静止机制,材料设计和潜在的应用
Shuxiang Zhang1, Xiuxue Lei1, Yongle Lv1
1Beijing Advanced Innovation Center for Materials Genome Engineering, State Key Laboratory for Advanced Metals and Materials, School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing 100083, PR China.
Carbohydrate polymers
|January 3, 2024
概括
基托 (CS) 由于其静血性质,显示出控制严重出血的前景. 增强酸盐的作用
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 聚合物化学 聚合物化学
背景情况:
- 由于手术或创伤造成的不受控制的出血会给健康带来重大风险,需要有效的止血解决方案.
- 酸盐 (CS) 是一个有前途的生物材料,由于其无毒性和固有的静血能力,用于静血.
- 在不影响其他功能的情况下提高基托桑的静血效果是一个关键的挑战.
研究的目的:
- 审查基托基材料的静血机制.
- 系统地总结基托基血静剂的各种形式和应用.
- 为了确定当前的挑战和未来的研究方向,在奇托桑血静性材料的设计.
主要方法:
- 血静机制的讨论:红细胞聚合,血小板相互作用和血蛋白相互作用.
- 基托桑材料形式 (粉末,海绵,水凝,纳米纤维) 的系统总结,重点是设计,制备和特性.
- 血静应用的详细描述,包括皮肤伤口,肝脏,动脉和心脏血静.
主要成果:
- 基托基材料通过诸如红细胞聚合和血小板激活等机制表现出静血性质.
- 不同形式的基托桑材料 (例如,海绵,水凝,纳米纤维) 为不同的出血场景提供了量身定制的解决方案.
- 在各种手术和创伤环境中证明了成功的应用,突出显示了奇托桑的多功能性.
结论:
- 基托桑基材料为开发先进的静血剂提供了一个多功能平台.
- 对功能设计的进一步研究对于优化基托桑在各种临床应用中的性能至关重要.
- 解决当前的挑战将为改善全球出血控制策略铺平道路.
相关概念视频
Introduction to Hemostasis
7.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
Extrinsic and Intrinsic Pathways of Hemostasis
7.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.8K


